Literature DB >> 26434602

Modulation of embryonic development due to mating with immunised males.

Ludmila A Gerlinskaya1, Svetlana O Maslennikova1, Margaret V Anisimova1, Nataly A Feofanova1, Evgenii L Zavjalov1, Galina V Kontsevaya1, Yuri M Moshkin1, Mikhail P Moshkin1.   

Abstract

The modification of pre- and postnatal development conferred by immunogenic stimulation of mothers provides a population-level adaptation mechanism for non-genetic transfer of maternal experiences to progeny. However little is known about the transmission of paternal immune experiences to offspring. Here, we show that immune priming of males 3-9 days before mating affects the growth and humoral environment of developing embryos of outbred (ICR) and inbred (C57BL and BALB/c) mice. Antigenic stimulation of fathers caused a significant increase in embryonic bodyweight as measured on Day 16 of pregnancy and altered other gestation parameters, such as feto-placental ratio. Pregnant females mated with immunised males were also characterised by changes in humoral conditions as shown by measurements of blood and amniotic progesterone, testosterone and granulocyte-macrophage colony-stimulating factor (GM-CSF) cytokine concentrations. These results emphasise the role of paternal effects of immune priming on the in utero environment and fetal growth.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 26434602     DOI: 10.1071/RD15173

Source DB:  PubMed          Journal:  Reprod Fertil Dev        ISSN: 1031-3613            Impact factor:   2.311


  2 in total

1.  TNFα is responsible for the canonical offspring number-size trade-off.

Authors:  S O Maslennikova; L A Gerlinskaya; G V Kontsevaya; M V Anisimova; S A Nedospasov; N A Feofanova; M P Moshkin; Y M Moshkin
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

2.  Mapping the past, present and future research landscape of paternal effects.

Authors:  Joanna Rutkowska; Malgorzata Lagisz; Russell Bonduriansky; Shinichi Nakagawa
Journal:  BMC Biol       Date:  2020-11-27       Impact factor: 7.431

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.